The Kevorkianization of Dolly

Scientists must learn lessons from Dr. Death to prevent a war over tissue engineering.

Written byGlenn McGee
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Since the cloning of Dolly the sheep, research involving nuclear transfer-derived cells - and intelligent debate about that research - has been plagued by a phenomenon you might call "kevorkianization." Whatever your view of physician-assisted suicide, the now-legendary convicted felon Jack Kevorkian was the last person on earth who should have been the public advocate for the procedure. Dropping off cadavers in a rusty Volkswagen van on the way to press conferences, he turned euthanasia into reality TV, extolling wisdom about the wishes and conditions of his "patients" and promoting a chain of euthanasia shops.

Kevorkian's untimely decision to make theater out of coping with suffering at the end of life resulted in the total collapse of public discussion about the national need to improve hospice care, nursing homes, and Medicare. To this day, far more attention has been focused on assisted suicide in Oregon than on the drug needs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies